Faculty of Medicine, Gazi University, Ankara, Türkiye.
Department of Pediatric Nephrology, Gazi University, Ankara, Türkiye.
Turk J Pediatr. 2024 Nov 16;66(5):649-657. doi: 10.24953/turkjpediatr.2024.4556.
Dent's disease (DD) is a rare X-linked recessive tubulopathy characterized by low molecular weight proteinuria, hypercalciuria, nephrocalcinosis/nephrolithiasis and chronic kidney disease. With this manuscript, we reported three patients diagnosed as DD in our department in the last 10 years and thereby described the genetics, pathophysiology, clinical presentation, course and management of the disease.
The first case was a male newborn who was consulted to our department after medullary nephrocalcinosis was detected. The second case was a 4-year-old boy who was treated with a diagnosis of urinary tract infection but was found to have proteinuria. Our last case was an 11-month-old male infant who was being followed up for recurrent urinary tract infection and who had millimetric crystalloids in the renal collecting system. Proteinuria and hypercalciuria were present in all cases. Variants were observed in the CLCN5 gene for the first two cases (c.1852G>A and c.1557+1G>T, respectively) and OCRL gene (c.952C>T) for the last case. All patients were recommended oral hydration and a low-salt diet, and hydrochlorothiazide and enalapril were started. No deterioration in kidney function was observed in any patient.
DD is a disease that shows different phenotypes even among individuals with mutations in the same gene. Therefore, it should be considered in all patients with hypercalciuria, proteinuria, nephrolithiasis or nephrocalcinosis with/without proximal tubular dysfunction especially in the early childhood period. Classical treatments for hypercalciuria should be utilized, and a patient-based treatment plan should be drawn especially for proteinuria.
Dent 病(DD)是一种罕见的 X 连锁隐性肾小管病,其特征为低分子量蛋白尿、高钙尿症、肾钙质沉着症/肾结石和慢性肾脏病。通过本文,我们报道了过去 10 年我们科室诊断的 3 例 DD 患者,从而描述了该疾病的遗传学、病理生理学、临床表现、病程和治疗方法。
第一例是一名男性新生儿,因发现髓质肾钙质沉着而被咨询至我科。第二例是一名 4 岁男孩,最初被诊断为尿路感染,但发现有蛋白尿。我们的最后一例是一名 11 个月大的男性婴儿,因反复尿路感染接受随访,其肾集合系统有毫米级结晶。所有病例均存在蛋白尿和高钙尿症。前两例观察到 CLCN5 基因的变异(分别为 c.1852G>A 和 c.1557+1G>T),最后一例观察到 OCRL 基因的变异(c.952C>T)。所有患者均被建议口服补液和低盐饮食,并开始使用氢氯噻嗪和依那普利。所有患者的肾功能均无恶化。
DD 是一种即使在同一基因的突变个体中也表现出不同表型的疾病。因此,对于所有有高钙尿症、蛋白尿、肾结石或肾钙质沉着症和/或近端肾小管功能障碍的患者,特别是在儿童早期,均应考虑到该疾病。应采用经典的高钙尿症治疗方法,并应根据患者的具体情况制定个体化的蛋白尿治疗方案。